Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders.
Looking for a particular PepGen employee's phone or email?
The PepGen annual revenue was $86.5 million in 2026.
James McArthur is the CEO of PepGen.
61 people are employed at PepGen.
PepGen is based in Boston, Massachusetts.
The NAICS codes for PepGen are [33, 54, 541].
The SIC codes for PepGen are [873, 87].